Page last updated: 2024-08-24

capecitabine and Testicular Neoplasms

capecitabine has been researched along with Testicular Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Breadner, D; Cheung, WY; Ding, PQ; Gill, S; Gipson, M; Kong, S; Lakkunarajah, S; Loree, JM; Mulder, KE; Spartlin, JL; Welch, SA1
Dong, Y; Fang, CT; Lin, SH; Meng, JC; Wu, JM; Zhang, A1
Bokemeyer, C; Grünwald, V; Hartmann, JT; Honecker, F; Kollmannsberger, C; Mayer, F; Oechsle, K; Rick, O1

Reviews

1 review(s) available for capecitabine and Testicular Neoplasms

ArticleYear
Colorectal cancer with testicular metastasis: A case report and literature review.
    Medicine, 2023, Mar-17, Volume: 102, Issue:11

    Topics: Adenocarcinoma; Bevacizumab; Capecitabine; Colonic Neoplasms; Humans; Male; Middle Aged; Testicular Neoplasms

2023

Trials

1 trial(s) available for capecitabine and Testicular Neoplasms

ArticleYear
An open-label, multicenter phase II trial of capecitabine in patients with cisplatin-refractory or relapsed germ cell tumors.
    Anti-cancer drugs, 2007, Volume: 18, Issue:3

    Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents; Blood Cell Count; Capecitabine; Cisplatin; Deoxycytidine; Drug Resistance, Neoplasm; Fluorouracil; Humans; Karnofsky Performance Status; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms; Treatment Outcome

2007

Other Studies

1 other study(ies) available for capecitabine and Testicular Neoplasms

ArticleYear
The influence of adjuvant chemotherapy dose intensity on overall survival in resected colon cancer: a multicentered retrospective analysis.
    BMC cancer, 2022, Nov-01, Volume: 22, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Canada; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Fluorouracil; Humans; Leucovorin; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Retrospective Studies; Testicular Neoplasms

2022